ArticleLeukemia2025

Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia.

Daniel Pollyea et al.PubMed ↗Publisher ↗

No numbers read from the abstract.